AR - Press Room

Japan Sexually Transmitted Diseases (STDs) Drug Market Segmentation, Healthcare, Analysis and Forecast 2018-2025

Press Release   •   Jun 14, 2018 06:34 BST

The global Sexually Transmitted Diseases (STDs) Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Japan plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Sexually Transmitted Diseases (STDs) Drug development status and future trend in Japan, focuses on top players in Japan, also splits Sexually Transmitted Diseases (STDs) Drug by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

Download Sample Copy Of This Report From Here: http://www.amecoresearch.com/sample/3892

The major players in Japan market include
Pfizer
Hoffmann La Roche
Bayer Healthcare
Eli Lilly
Johnson & Johnson
Bristol-Myers Squibb
AbbVie, Inc.
Gilead Sciences
GlaxoSmithKline Plc
Merck & Co., Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
by Disease Type
Chlamydia
Gonorrhea
Syphilis
Genital herpes
HPV
HIV / AIDS
by Therapy Class
Antibiotics
Antiviral / Antiretrovirals
Vaccines

On the basis of the end users/Application, this report covers
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Table of Contents

Japan Sexually Transmitted Diseases (STDs) Drug Market Research Report 2018
1 Sexually Transmitted Diseases (STDs) Drug Overview
1.1 Product Overview and Scope of Sexually Transmitted Diseases (STDs) Drug
1.2 Classification of Sexually Transmitted Diseases (STDs) Drug by Product Category
1.2.1 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Comparison by Type (2013-2025)
1.2.2 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Market Share by Type in 2017
1.2.3 Chlamydia
1.2.4 Gonorrhea
1.2.5 Syphilis
1.2.6 Genital herpes
1.2.7 HPV
1.2.8 HIV / AIDS
1.3 Japan Sexually Transmitted Diseases (STDs) Drug Market by Application/End Users
1.3.1 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Japan Revenue and Sales of Sexually Transmitted Diseases (STDs) Drug (2013-2025)
1.4.1 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2025)
1.4.2 Japan Sexually Transmitted Diseases (STDs) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 Japan Sexually Transmitted Diseases (STDs) Drug Market Competition by Players/Manufacturers
2.1 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Japan Sexually Transmitted Diseases (STDs) Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Japan Sexually Transmitted Diseases (STDs) Drug Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 Japan Sexually Transmitted Diseases (STDs) Drug Market Competitive Situation and Trends
2.4.1 Japan Sexually Transmitted Diseases (STDs) Drug Market Concentration Rate
2.4.2 Japan Sexually Transmitted Diseases (STDs) Drug Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers Sexually Transmitted Diseases (STDs) Drug Manufacturing Base Distribution, Sales Area, Product Type

3 Japan Sexually Transmitted Diseases (STDs) Drug Sales and Revenue (Value) by Type (2013-2018)
3.1 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
3.2 Japan Sexually Transmitted Diseases (STDs) Drug Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Japan Sexually Transmitted Diseases (STDs) Drug Price (USD/Unit) by Type (2013-2018)
3.4 Japan Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (%) by Type (2013-2018)

4 Japan Sexually Transmitted Diseases (STDs) Drug Sales by Application (2013-2018)
4.1 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Market Share by Application (2013-2018)
4.2 Japan Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 Japan Sexually Transmitted Diseases (STDs) Drug Players/Suppliers Profiles and Sales Data
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Pfizer Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 Hoffmann La Roche
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Bayer Healthcare
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Eli Lilly
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Johnson & Johnson
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Bristol-Myers Squibb
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 AbbVie, Inc.
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
5.8 Gilead Sciences
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.8.2.1 Product A
5.8.2.2 Product B
5.8.3 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.8.4 Main Business/Business Overview
5.9 GlaxoSmithKline Plc
5.9.1 Company Basic Information, Manufacturing Base and Competitors
5.9.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.9.2.1 Product A
5.9.2.2 Product B
5.9.3 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.9.4 Main Business/Business Overview
5.10 Merck & Co., Inc.
5.10.1 Company Basic Information, Manufacturing Base and Competitors
5.10.2 Sexually Transmitted Diseases (STDs) Drug Product Category, Application and Specification
5.10.2.1 Product A
5.10.2.2 Product B
5.10.3 Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.10.4 Main Business/Business Overview

6 Sexually Transmitted Diseases (STDs) Drug Manufacturing Cost Analysis
6.1 Sexually Transmitted Diseases (STDs) Drug Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Sexually Transmitted Diseases (STDs) Drug

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Sexually Transmitted Diseases (STDs) Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Sexually Transmitted Diseases (STDs) Drug Major Manufacturers in 2017
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 Japan Sexually Transmitted Diseases (STDs) Drug Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
10.2 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Forecast by Type (2018-2025)
10.3 Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Forecast by Application (2018-2025)

11 Research Findings and Conclusion

Buy Now This Report From Here: http://www.amecoresearch.com/buy/3892

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Call: 44 20 3286 1546 | Email: sales@amecoresearch.com